Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases
Britt A.E. Dhaenens, Günter Heimann, Annette Bakker, Marco Nievo, Rosalie E. Ferner, D. Gareth Evans, Pierre Wolkenstein, Jonas Leubner, Cornelia Potratz, Charlotte Carton, Uchenna Iloeje, George Kirk, Jaishri O. Blakeley, Scott Plotkin, Michael J. Fisher, Ae Rang Kim, Pablo Hernáiz Driever, Amedeo A. Azizi, Brigitte C. Widemann, Andrea GrossTom Parke, Eric Legius, Rianne Oostenbrink
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases'. Together they form a unique fingerprint.